showed a trendP <0.01
Over four weeks, immediate and double-injection groups considerably showed a trend of increase in BMS scores that become significantly different compared to the control (vehicle treatment) group ( P <0.01).
Over four weeks, immediate and double-injection groups considerably showed a trend of increase in BMS scores that become significantly different compared to the control (vehicle treatment) group ( P <0.01).
Subsequently, an increasing trend in body weight was observed in the control and sham groups during 4 weeks following SCI, however, ibrutinib administration immediately or 12-hour after SCI slowed this increasing trend.